Acetylation of the HIV-1 Tat protein: an in vitro study
- First Online:
- Cite this article as:
- Dormeyer, W., Dorr, A., Ott, M. et al. Anal Bioanal Chem (2003) 376: 994. doi:10.1007/s00216-003-2058-z
- 128 Downloads
In the last few years, the understanding of lysine acetylation as a regulatory post-translational modification of proteins in cell signalling cascades has increased. It is now known that not only histones but also non-histone factors can serve as substrates of different acetyltransferase enzymes. Acetylated lysine residues in non-histone factors are often identified using radioactive labelling experiments and immunochemical analysis of synthetic peptides. In this study of the human immunodeficiency virus 1 (HIV-1) Tat protein, we demonstrate the benefits of matrix-assisted laser desorption/ionisation mass spectrometry, proteolytic digestion and Edman sequencing for the mapping of acetylation sites. We confirmed that the HIV-1 Tat protein is acetylated in vitro by the acetyltransferase p300 at a specific lysine residue at position 50 in its RNA binding region. Furthermore, we showed that the Tat cysteine-rich region is acetylated at multiple cysteine residues in the absence of enzyme. Since this non-enzymatic cysteine acetylation occurs independently from the surrounding peptide sequence, we consider the presence of cysteine residues in acetylated peptides an important factor for the interpretation of in vitro acetylation assays in general.
KeywordsAcetylationMALDI-TOF mass spectrometryEdman sequencingHIV-1 TatHistone acetyltransferase p300
Acetyl coenzyme A